Greece vs Uruguay: HIV/AIDS deaths averted by antiretroviral therapy
Greece
553.75 deaths
in 2024
Uruguay
516 deaths
in 2022
Greece rank
88th
Uruguay rank
91st
HIV/AIDS deaths averted by antiretroviral therapy over time
- Greece
- Uruguay
How they compare
Greece currently reports 553.75 deaths against 516 deaths in Uruguay, a difference of 37.75 deaths.
That makes Greece's figure about 1.1 times Uruguay's.
The two have swapped places 1 time across 33 shared years of data; in 1990 it was Uruguay ahead.
Greece ranks 88th and Uruguay ranks 91st of 157 countries.
Greece has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Greece | Uruguay | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 64.77 deaths | 25 deaths | 39.77 deaths | Greece |
| 2000s | 267.56 deaths | 166.5 deaths | 101.06 deaths | Greece |
| 2010s | 455.55 deaths | 364 deaths | 91.55 deaths | Greece |
| 2020s | 549.9 deaths | 487 deaths | 62.9 deaths | Greece |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Greece or Uruguay?
- Greece, at 553.75 deaths against 516 deaths in Uruguay as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Greece and Uruguay?
- 37.75 deaths, with Greece ahead.
- How many years of comparable data are there for Greece and Uruguay?
- 33 years are reported by both, from 1990 to 2022.
- How do Greece and Uruguay rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Greece ranks 88th and Uruguay ranks 91st of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.